Bristol-Myers Squibb Co (BMY)
58.90
+0.68
(+1.16%)
USD |
NYSE |
Nov 22, 16:00
58.87
-0.04
(-0.06%)
After-Hours: 20:00
Bristol-Myers Squibb Research and Development Expense (Quarterly): 2.374B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.374B |
| June 30, 2024 | 2.899B |
| March 31, 2024 | 2.695B |
| December 31, 2023 | 2.478B |
| September 30, 2023 | 2.242B |
| June 30, 2023 | 2.258B |
| March 31, 2023 | 2.321B |
| December 31, 2022 | 2.51B |
| September 30, 2022 | 2.418B |
| June 30, 2022 | 2.321B |
| March 31, 2022 | 2.26B |
| December 31, 2021 | 2.518B |
| September 30, 2021 | 2.98B |
| June 30, 2021 | 2.478B |
| March 31, 2021 | 2.219B |
| December 31, 2020 | 3.75B |
| September 30, 2020 | 2.499B |
| June 30, 2020 | 2.522B |
| March 31, 2020 | 2.372B |
| December 31, 2019 | 2.097B |
| September 30, 2019 | 1.378B |
| June 30, 2019 | 1.325B |
| March 31, 2019 | 1.348B |
| December 31, 2018 | 1.367B |
| September 30, 2018 | 1.28B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.435B |
| March 31, 2018 | 1.25B |
| December 31, 2017 | 1.925B |
| September 30, 2017 | 1.561B |
| June 30, 2017 | 1.679B |
| March 31, 2017 | 1.303B |
| December 31, 2016 | 1.472B |
| September 30, 2016 | 1.138B |
| June 30, 2016 | 1.266B |
| March 31, 2016 | 1.136B |
| December 31, 2015 | 1.916B |
| September 30, 2015 | 1.132B |
| June 30, 2015 | 1.856B |
| March 31, 2015 | 1.016B |
| December 31, 2014 | 1.189B |
| September 30, 2014 | 983.00M |
| June 30, 2014 | 1.416B |
| March 31, 2014 | 946.00M |
| December 31, 2013 | 957.00M |
| September 30, 2013 | 893.00M |
| June 30, 2013 | 951.00M |
| March 31, 2013 | 930.00M |
| December 31, 2012 | 1.082B |
| September 30, 2012 | 951.00M |
| June 30, 2012 | 962.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.097B
Minimum
Dec 2019
3.75B
Maximum
Dec 2020
2.511B
Average
2.448B
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 4.952B |
| Eli Lilly and Co | 2.734B |
| Merck & Co Inc | 5.862B |
| Pfizer Inc | 2.598B |
| AbbVie Inc | 2.13B |